cystine has been researched along with gemcitabine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gout, PW; Ling, V; Lo, M; Wang, YZ | 1 |
| Boytim, ML; Cohen, SJ; Conkling, P; Davis, P; Dorr, RT; Hersh, EM; Modiano, MR; Patt, YZ; Zalupski, MM | 1 |
1 trial(s) available for cystine and gemcitabine
| Article | Year |
|---|---|
A phase I study of imexon plus gemcitabine as first-line therapy for advanced pancreatic cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Cohort Studies; Cystine; Deoxycytidine; Dose-Response Relationship, Drug; Female; Gemcitabine; Half-Life; Hexanones; Humans; Male; Middle Aged; Pancreatic Neoplasms; Sulfhydryl Compounds; Tomography, X-Ray Computed | 2010 |
1 other study(ies) available for cystine and gemcitabine
| Article | Year |
|---|---|
The xc- cystine/glutamate antiporter: a mediator of pancreatic cancer growth with a role in drug resistance.
Topics: Amino Acid Transport System y+; Antineoplastic Agents; Base Sequence; Blotting, Western; Cell Line, Tumor; Cystine; Deoxycytidine; DNA Primers; Drug Resistance, Neoplasm; Gemcitabine; Glutathione; Humans; Immunohistochemistry; Microscopy, Fluorescence; Oxidative Stress; Pancreatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction | 2008 |